1389 related articles for article (PubMed ID: 17379492)
1. Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.
Xu J; Jiang F; Nayeri F; Zetterström O
Respir Med; 2007 Jul; 101(7):1447-54. PubMed ID: 17379492
[TBL] [Abstract][Full Text] [Related]
2. Smoking affects eotaxin levels in asthma patients.
Krisiukeniene A; Babusyte A; Stravinskaite K; Lotvall J; Sakalauskas R; Sitkauskiene B
J Asthma; 2009 Jun; 46(5):470-6. PubMed ID: 19544167
[TBL] [Abstract][Full Text] [Related]
3. [Eotaxin in induced sputum in patients with asthma and chronic bronchitis: relationship with airway inflammation].
Fu J; Chen P; Xiang X
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jan; 25(1):29-32. PubMed ID: 11953096
[TBL] [Abstract][Full Text] [Related]
4. [Airway inflammation and peripheral airway function in asthmatic patients with different control levels].
Pan Y; Huang KW; Ye Q; Liu XS; Wu BM; Zhang J; Chang XH; Lu Y; Wang C
Zhonghua Jie He He Hu Xi Za Zhi; 2009 Sep; 32(9):679-84. PubMed ID: 20079282
[TBL] [Abstract][Full Text] [Related]
5. Exhaled breath condensate levels of eotaxin and macrophage-derived chemokine in stable adult asthma patients.
Ko FW; Lau CY; Leung TF; Wong GW; Lam CW; Lai CK; Hui DS
Clin Exp Allergy; 2006 Jan; 36(1):44-51. PubMed ID: 16393265
[TBL] [Abstract][Full Text] [Related]
6. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
7. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media.
Iino Y; Kakizaki K; Katano H; Saigusa H; Kanegasaki S
Clin Exp Allergy; 2005 Oct; 35(10):1370-6. PubMed ID: 16238798
[TBL] [Abstract][Full Text] [Related]
8. Profiles of proinflammatory cytokines in sputum from different groups of severe asthmatic patients.
Dente FL; Carnevali S; Bartoli ML; Cianchetti S; Bacci E; Di Franco A; Vagaggini B; Paggiaro P
Ann Allergy Asthma Immunol; 2006 Sep; 97(3):312-20. PubMed ID: 17042136
[TBL] [Abstract][Full Text] [Related]
9. Delayed eosinophil apoptosis in asthma.
Kankaanranta H; Lindsay MA; Giembycz MA; Zhang X; Moilanen E; Barnes PJ
J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):77-83. PubMed ID: 10887309
[TBL] [Abstract][Full Text] [Related]
10. Persistent airway inflammation and bronchial hyperresponsiveness in patients with totally controlled asthma.
Hanxiang N; Jiong Y; Yanwei C; Dunshuang W; Xuhong D; Xiaojun W; Changsheng L
Int J Clin Pract; 2008 Apr; 62(4):599-605. PubMed ID: 17537187
[TBL] [Abstract][Full Text] [Related]
11. Eosinophil apoptosis in induced sputum from patients with seasonal allergic rhinitis and with asymptomatic and symptomatic asthma.
Foresi A; Teodoro C; Leone C; Pelucchi A; D'Ippolito R; Chetta A; Olivieri D
Ann Allergy Asthma Immunol; 2000 Apr; 84(4):411-6. PubMed ID: 10795649
[TBL] [Abstract][Full Text] [Related]
12. Characterization of airway inflammation after repeated exposures to occupational agents.
Lemière C; Chaboilliez S; Trudeau C; Taha R; Maghni K; Martin JG; Hamid Q
J Allergy Clin Immunol; 2000 Dec; 106(6):1163-70. PubMed ID: 11112901
[TBL] [Abstract][Full Text] [Related]
13. Eotaxin level in induced sputum is increased in patients with bronchial asthma and in smokers.
Yamamoto K; Takanashi S; Hasegawa Y; Kanehira Y; Kaizuka M; Okumura K
Respiration; 2003; 70(6):600-5. PubMed ID: 14732790
[TBL] [Abstract][Full Text] [Related]
14. BAL eotaxin and IL-5 in asthma, and the effects of inhaled corticosteroid and beta2 agonist.
Feltis BN; Reid DW; Ward C; Walters EH
Respirology; 2004 Nov; 9(4):507-13. PubMed ID: 15612963
[TBL] [Abstract][Full Text] [Related]
15. [Detection of eotaxin and its clinical diagnosis value in patients with bronchial asthma].
Liu ZJ; Ren YL; Lin JY; Ni AP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):298-301. PubMed ID: 15266834
[TBL] [Abstract][Full Text] [Related]
16. Eotaxin in serum of patients with asthma or chronic obstructive pulmonary disease: relationship with eosinophil cationic protein and lung function.
Jahnz-Ró yk K; Plusa T; Mierzejewska J
Mediators Inflamm; 2000; 9(3-4):175-9. PubMed ID: 11132775
[TBL] [Abstract][Full Text] [Related]
17. Contribution of eotaxin-1 to eosinophil chemotactic activity of moderate and severe asthmatic sputum.
Dent G; Hadjicharalambous C; Yoshikawa T; Handy RL; Powell J; Anderson IK; Louis R; Davies DE; Djukanovic R
Am J Respir Crit Care Med; 2004 May; 169(10):1110-7. PubMed ID: 15001461
[TBL] [Abstract][Full Text] [Related]
18. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
[TBL] [Abstract][Full Text] [Related]
19. Effects of oral prednisone on sputum eosinophils and cytokines in patients with severe refractory asthma.
Dente FL; Bacci E; Bartoli ML; Cianchetti S; Costa F; Di Franco A; Malagrinò L; Vagaggini B; Paggiaro P
Ann Allergy Asthma Immunol; 2010 Jun; 104(6):464-70. PubMed ID: 20568377
[TBL] [Abstract][Full Text] [Related]
20. Changes in serum eotaxin and eosinophil cationic protein levels, and eosinophil count during treatment of childhood asthma.
Chu YT; Chiang W; Wang TN; Hung CH; Jong YJ; Wu JR
J Microbiol Immunol Infect; 2007 Apr; 40(2):162-7. PubMed ID: 17446966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
